RESMED INC — Director's Dealing 2014

Feb 7, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-02-05

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-05	ResMed Common Stock	M	7500	$15.52	Acquired	108025.087	Direct
2014-02-05	ResMed Common Stock	S	7500	$43.0928	Disposed	100525.087	Direct
2014-02-05	ResMed Common Stock	S	500	$43.16	Disposed	100025.087	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-05	ResMed Common Stock Options	$15.520	M	7500	Disposed	2015-11-20	ResMed Common Stock (7500)	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.